Objects
Greer, Peter, Martin, Jarad, Sidhom, Mark, Hunter, Perry, Pichler, Peter, Choi, Jae Hyuk, Best, Leah, Smart, Joanne, Young, Tony, Jameson, Michael, Afinidad, Tess, Wratten, Chris, Denham, James, Holloway, Lois, Sridharan, Swetha, Rai, Robba, Liney, Gary, Raniga, Parnesh, Dowling, Jason. Frontiers Research Foundation; 2019. A multi-center prospective study for implementation of an MRI-only prostate treatment planning workflow.
Phonlakrai, Monchai, Ramadan, Saadallah, Lamichhane, Bishnu, Bollipo, Steven, Greer, Peter, Simpson, John, Gholizadeh, Neda, Arm, Jameen, Skehan, Kate, Goodwin, Jonathan, Trada, Yuvnik, Martin, Jarad, Sridharan, Swetha. John Wiley & Sons; 2023. Determination of hepatic extraction fraction with gadoxetate low-temporal resolution DCE-MRI-based deconvolution analysis: validation with ALBI score and Child-Pugh class.
Sridharan, Swetha, Steigler, Allison, Attia, John, Holliday, Elizabeth G., Denham, James W., Spry, Nigel A., Joseph, David, Lamb, David S., Matthews, John H., Atkinson, Chris, Tai, Keen-Hun, Duchesne, Gillian, Christie, David. Elsevier; 2016. Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial.
O'Connor, Laura M., Dowling, Jason A., Choi, Jae Hyuk, Martin, Jarad, Warren-Forward, Helen, Richardson, Haylea, Best, Leah, Skehan, Kate, Kumar, Mahesh, Govindarajulu, Geetha, Sridharan, Swetha, Greer, Peter B.. BioMed Central; 2022. Validation of an MRI-only planning workflow for definitive pelvic radiotherapy.
Jones, Michael Peter, Hruby, George, Martin, Jarad, Metser, Ur, Sridharan, Swetha, Capp, Anne, Kumar, Malesh, Gallagher, Sarah, Rutherford, Natalie, Holder, Carl, Oldmeadow, Christopher. BioMed Central; 2019. FDG-PET parameters predict for recurrence in anal cancer - results from a prospective, multicentre clinical trial.
Dempsey, Claire, Govindarajulu, Geetha, Sridharan, Swetha, Capp, Anne, O'Brien, Peter. Springer Netherlands; 2014. Implications for dosimetric changes when introducing MR-guided brachytherapy for small volume cervix cancer: a comparison of CT and MR-based treatments in a single centre.
Richardson, Matthew, Skehan, Kate, Wilton, Lee, Sams, Joshua, Samuels, Justin, Goodwin, Jonathan, Greer, Peter, Sridharan, Swetha, Martin, Jarad. John Wiley & Sons; 2021. Visualising the urethra for prostate radiotherapy planning.
Jones, Michael, Hruby, George, Holder, Carl, Oldmeadow, Christopher, Martin, Jarad, Coolens, Catherine, Driscoll, Brandon, Stanwell, Peter, Kumar, Mahesh, Capp, Anne, Sridharan, Swetha, Arm, Jameen, Gallagher, Sarah. Elsevier Ireland; 2020. A prospective, multi-centre trial of multi-parametric MRI as a biomarker in anal carcinoma.
Loh, Jasmin, Baker, Katie, Sridharan, Swetha, Greer, Peter, Wratten, Chris, Capp, Anne, Gallagher, Sarah, Martin, Jarad. BioMed Central; 2015. Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks?.
Wegener, Eric, Samuels, Justin, Sidhom, Mark, Trada, Yunvik, Sridharan, Swetha, Dickson, Samual, McLeod, Nichola, Martin, Jarad M.. MDPI; 2023. Virtual HDR Boost for Prostate Cancer: Rebooting a Classic Treatment Using Modern Tech.
Phonlakrai, Monchai, Ramadan, Saadallah, Greer, Peter, Simpson, John, Skehan, Kate, Goodwin, Jonathan, Trada, Yuvnik, Martin, Jarad, Sridharan, Swetha, Gan, Lay Theng, Siddique, Sabbir Hossain. John Wiley & Sons; 2023. Non-contrast based approach for liver function quantification using Bayesian-based intravoxel incoherent motion diffusion weighted imaging: A pilot study.
Sridharan, Swetha, Day, Fiona, Loh, Jasmin, Lynam, James, Smart, Joanne, Holt, Brandon, Mandaliya, Hiren, Bonaventura, Anthony, Kumar, Mahesh, Martin, Jarad. BioMed Central Ltd.; 2022. Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer.
Skehan, Kate, Richardson, Matthew, O'Connor, Laura M., Dickson, Samuel, Martin, Kate, Govindarajulu, Geetha, Sridharan, Swetha. John Wiley & Sons; 2024. Viscous Aqueous Gel Illustrating Natural Anatomy: The VAGINA method in gynaecological MRI simulation.
Siva, Shankar, Bressel, Mathias, Lin, Charles, Raman, Avi, Hardcastle, Nicholas, Hofman, Michael S., De Abreu Lourenco, Richard, Shaw, Mark, Mancuso, Pascal, Moon, Daniel, Wong, Lih-Ming, Lawrentschuk, Nathan, Sidhom, Mark, Wood, S, Brook, NR, Kron, T, Martin, Jarad, Pryor, D, FASTRACK II Investigator Group,, Sridharan, Swetha, Vanneste, Ben G. L., Davey, Ryan, Montgomery, Rebecca, Ruben, Jeremy, Foroudi, Farshad, Higgs, Braden. The Lancet Publishing Group; 2024. Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.